Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.09 USD | -0.06% | -0.19% | +7.81% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
Financials (USD)
Sales 2024 * | 447M | Sales 2025 * | 537M | Capitalization | 3.42B |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 36M | EV / Sales 2024 * | 6.93 x |
Net cash position 2024 * | 329M | Net cash position 2025 * | 370M | EV / Sales 2025 * | 5.69 x |
P/E ratio 2024 * |
-2,135
x | P/E ratio 2025 * |
95.7
x | Employees | 797 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Axonics, Inc.
1 day | -0.06% | ||
1 week | -0.19% | ||
1 month | +0.78% | ||
3 months | -1.25% | ||
6 months | +19.82% | ||
Current year | +7.81% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 51 | 12-12-31 | |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Kari Keese
DFI | Director of Finance/CFO | 39 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Carrel
CHM | Chairman | 53 | 19-02-26 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 19-04-07 |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 11 M€ | -6.03% | - | |
0.09% | 430 M€ | -.--% | ||
0.05% | 746 M€ | -.--% | - | |
0.04% | 234 M€ | +8.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 67.09 | -0.06% | 360,459 |
24-05-30 | 67.13 | +0.18% | 322,201 |
24-05-29 | 67.01 | -0.18% | 386,915 |
24-05-28 | 67.13 | -0.13% | 299,937 |
24-05-24 | 67.22 | -0.16% | 291,184 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.81% | 3.42B | |
+13.73% | 130B | |
-8.17% | 10.99B | |
-4.33% | 8.35B | |
+41.80% | 5.67B | |
-21.94% | 4.72B | |
-10.26% | 2.76B | |
-10.29% | 2.11B | |
-13.58% | 1.92B | |
-27.77% | 1.68B |
- Stock Market
- Equities
- AXNX Stock